Highlights
NASDAQ: LGND       Ligand Pharm Cmn
Last Price Today's Change   Day's Range   Trading Volume
108.67   +3.55 (3.38%)  105.88 - 109.65  134,570

Overview

Avg Volume (4 weeks):0
4 Weeks Range:102.56 - 109.65
52 Weeks Range:87.50 - 139.79
Average Price Target: 94.00
Price Target Upside/Downside: -14.67

Headlines



No recent Headlines for this stock.


Business Background

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others.

  Be the first to like this.
 


 

4459  2643  565  656 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 24.215+0.585 
 JNUG 4.368-0.882 
 BABY 40.85+0.25 
 AKS 6.49-0.63 
 NUGT 8.06-1.30 
 SPY 238.79+1.62 
 GDX 22.115-1.085 
 ABX 17.083-1.957 
 FCX 12.915+0.685 
 XLF 23.965+0.285 
Partners & Brokers